The quest for myocardial viability: Is there a role for nitrate-enhanced imaging?

Journal of Nuclear Cardiology

Volumn 10, Issue 6, 2003, Pages 696-699

  Di Carli, Marcelo F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; NITRATE; TETROFOSMIN TC 99M; VASODILATOR AGENT;

CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE SEVERITY; EDITORIAL; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; IMAGE ENHANCEMENT; PATIENT SELECTION; PERMEABILITY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM;

EID: 0347660942     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2003.09.001     Document Type: Editorial

References (27)

1. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331-6.
2. Emond M, Mock MB, Davis KB, et al. Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation 1994;90:2645-57.
3. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-95.
4. Bounous EP, Mark DB, Pollock BG, et al. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation 1988;78:I151-7.
5. Report from the Bar Harbor conference on nuclear cardiology. J Nucl Cardiol 2001;8:224-316.
6. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117:211-21.
7. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 1982;66:1146-9.
8. Di Carli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436-44.
9. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
10. Di Carli MF. Assessment of myocardial viability post myocardial infarction. J Nucl Cardiol 2002;9:229-35.
11. Bonow RO, Dilsizian V. Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium. J Nucl Med 1992;33:815-8.
12. 99Tc-sestamibi. Circulation 1994;89:2552-61.
13. Bisi G, Sciagra R, Santoro GM, Zerauschek F, Fazzini PF. Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibility. J Nucl Med 1994;35: 1274-8.
14. Galli M, Marcassa C, Imparato A, et al. Effects of nitroglycerin by technetium-99m sestamibi tomoscintigraphy on resting regional myocardial hypoperfusion in stable patients with healed myocardial infarction. Am J Cardiol 1994;74:843-8.
15. Bisi G, Sciagra R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282-9.
16. Maurea S, Cuocolo A, Soricelli A, et al. Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease. J Nucl Med 1995;36:1945-52.
17. Li ST, Liu XJ, Lu ZL, et al. Quantitative analysis of technetium 99m 2-methoxyisobutyl isonitrile single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization. J Nucl Cardiol 1996;3:457-63.
18. Sciagra R, Bisi G, Santoro GM, et al. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol 1997;30:384-91.
19. He W, Acampa W, Mainolfi C, et al. Tc-99m tetrofosmin tomography after nitrate administration in patients with ischemic left ventricular dysfunction: relation to metabolic imaging by PET. J Nucl Cardiol. In press 2003.
20. Abrams J. Mechanism of action of the organic nitrates in the treatment of myocardial ischemia. Am J Cardiol 1992;70:30B-42B.
21. Bax JJ, Poldermans D, Elhendy A, Boersma E, Rahimtoola SH. Sensitivity, specificity, and predictive accuracies of various non-invasive techniques for detecting hibernating myocardium. Curr Probl Cardiol 2001;26:141-86.
22. Di Carli MF, Hachamovitch R, Berman DS. The art and science of predicting post-revascularization improvement in LV function in patients with severely depressed LV function. J Am Coll Cardiol 2002;40:1744-7.
23. Beanlands RSB, Ruddy TD, deKemp RA, et al. PET and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of LV function. J Am Coll Cardiol 2002;40:1735-43.
24. Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163-9.
25. Samady H, Elefteriades JA, Abbott BG, et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 1999;100:1298-304.
26. Baker DW, Jones R, Hodges J, et al. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 1994;272:1528-34.
27. Freeman AP, Walsh WF, Giles RW, et al. Early and long-term results of coronary artery bypass grafting with severely depressed left ventricular performance. Am J Cardiol 1984;54:749-54.